eprintid: 97684
rev_number: 3
eprint_status: archive
dir: disk0/00/09/76/84
datestamp: 2026-06-19 06:18:55
lastmod: 2026-06-19 06:18:55
status_changed: 2026-06-19 06:18:55
type: article
metadata_visibility: show
creators_name: Jurayev J.S.,, Jurayev J.S.,
creators_name: Karshiev.M.A, Karshiev.M.A
creators_name: Uralov A.A, Uralov A.A
title: RECURRENCE OF CHCV AFTER THE USE OF DIRECT ANTIVIRAL  DRUGS: CLINICS, DIAGNOSIS, TREATMENT AND OUTCOMES
ispublished: pub
keywords: extrahepatic manifestations, relapse, IFN + riboverine, retreatment of  relapse HCV RNA genotype 1b.
abstract: Viral hepatitis C is one of the leading liver diseases. According to WHO, 70 million people are infected with this disease. HCV kills 290,000 people every year. In 95% of patients, the disease becomes chronic, and the main complications are fibrosis and cirrhosis of the liver. In some cases, a relapse is observed, despite treatment with antiviral drugs.
date: 2024-05-12
official_url: https://universalconference.us/index.php/icmse/article/view/1301
full_text_status: public
publication: INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION
volume: 1
number: 4
pagerange: 98-99
citation:   Jurayev J.S.,, Jurayev J.S.,, Karshiev.M.A, Karshiev.M.A, Uralov A.A, Uralov A.A  (2024) RECURRENCE OF CHCV AFTER THE USE OF DIRECT ANTIVIRAL DRUGS: CLINICS, DIAGNOSIS, TREATMENT AND OUTCOMES.  INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION, 1 (4).  pp. 98-99.      
document_url: https://arxiv.universalpublishings.com/id/eprint/97684/1/Jurayev_J.S._98-99.pdf